PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Disease Reportssubarachnoid hemorrhage
MeSH D013345 - subarachnoid hemorrhage
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D020300:Intracranial hemorrhages
0 Companies
0 Drugs
Success rate
D013345: 
Subarachnoid hemorrhage
34 Companies
2 Drugs
$
Success rate
D020206:Traumatic subarachnoid hemorrhage
0 Companies
0 Drugs
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
MylanTranexamic acid Tranexamic Acid  2011-11-03   
BayerNimodipine Nimotop  1988-12-28   
PfizerTranexamic acid Cyklokapron  1986-12-30   
Aurobindo PharmaTranexamic acid Tranexamic Acid  2015-09-21   
Zydus TherapeuticsTranexamic acid Tranexamic Acid  2017-07-17   
Sun Pharmaceutical IndustriesNimodipine Nimodipine  2007-04-17   
ApotexTranexamic acid Tranexamic Acid  2014-01-27   
Amneal PharmaceuticalsTranexamic acid Tranexamic Acid  2017-02-28   
Micro LaboratoriesTranexamic acid Tranexamic Acid  2017-06-27   
BionPharmaNimodipine Nimodipine  2008-01-17   
Tranexamic acid Tranexamic Acid  2025-08-19   
1
2
3
4
>
Clinical Trials
Historical Success Rate
Phase 1
91%
20/22
Phase 2
45%
19/42
Phase 3
25%
8/32
Approved: 2Overall Success rate: 10%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Pfizer
Tranexamic acid
1
2
3
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use